José-Luis Ríos

520 total citations
10 papers, 456 citations indexed

About

José-Luis Ríos is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, José-Luis Ríos has authored 10 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Plant Science and 2 papers in Pharmacology. Recurrent topics in José-Luis Ríos's work include Natural product bioactivities and synthesis (4 papers), Phytochemicals and Antioxidant Activities (2 papers) and Natural Antidiabetic Agents Studies (2 papers). José-Luis Ríos is often cited by papers focused on Natural product bioactivities and synthesis (4 papers), Phytochemicals and Antioxidant Activities (2 papers) and Natural Antidiabetic Agents Studies (2 papers). José-Luis Ríos collaborates with scholars based in Spain, Argentina and Japan. José-Luis Ríos's co-authors include Salvador Máñez, Rosa M. Giner, M. Carmen Recio, Miguel Cerdá‐Nicolás, José M. Prieto, Esperanza Bas, Guillermo Schinella, Flavio Francini, José Miguel Escandell and Marı́a-Carmen Recio and has published in prestigious journals such as Biochemical Pharmacology, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

José-Luis Ríos

10 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José-Luis Ríos Spain 10 246 169 92 80 65 10 456
Kunio Kumaki Japan 11 250 1.0× 203 1.2× 62 0.7× 73 0.9× 47 0.7× 16 467
In‐Tae Kim South Korea 8 246 1.0× 133 0.8× 77 0.8× 57 0.7× 101 1.6× 8 476
Chia-Chung Hou Taiwan 8 162 0.7× 74 0.4× 119 1.3× 47 0.6× 71 1.1× 8 471
Shixiu Feng China 15 252 1.0× 207 1.2× 77 0.8× 35 0.4× 58 0.9× 36 509
Changling Hu China 17 402 1.6× 186 1.1× 79 0.9× 104 1.3× 57 0.9× 35 715
Guang‐Jian Du United States 12 441 1.8× 106 0.6× 66 0.7× 64 0.8× 166 2.6× 16 641
Shihui Qian China 13 296 1.2× 188 1.1× 86 0.9× 36 0.5× 84 1.3× 48 493
Kun-Ho Son South Korea 15 303 1.2× 143 0.8× 92 1.0× 53 0.7× 76 1.2× 34 526
Jiaming Sun China 12 263 1.1× 96 0.6× 57 0.6× 46 0.6× 74 1.1× 47 456
Sam-Sik Kang South Korea 12 241 1.0× 141 0.8× 44 0.5× 65 0.8× 55 0.8× 48 459

Countries citing papers authored by José-Luis Ríos

Since Specialization
Citations

This map shows the geographic impact of José-Luis Ríos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José-Luis Ríos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José-Luis Ríos more than expected).

Fields of papers citing papers by José-Luis Ríos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José-Luis Ríos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José-Luis Ríos. The network helps show where José-Luis Ríos may publish in the future.

Co-authorship network of co-authors of José-Luis Ríos

This figure shows the co-authorship network connecting the top 25 collaborators of José-Luis Ríos. A scholar is included among the top collaborators of José-Luis Ríos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José-Luis Ríos. José-Luis Ríos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ríos, José-Luis, Isabel Andújar, Guillermo Schinella, & Flavio Francini. (2019). Modulation of Diabetes by Natural Products and Medicinal Plants via Incretins. Planta Medica. 85(11/12). 825–839. 12 indexed citations
2.
Francini, Flavio, Guillermo Schinella, & José-Luis Ríos. (2018). Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus. Mini-Reviews in Medicinal Chemistry. 19(11). 880–901. 31 indexed citations
3.
Escandell, José Miguel, Pawan Kaler, M. Carmen Recio, et al.. (2008). Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: The role of p53 and p21. Biochemical Pharmacology. 76(2). 198–207. 41 indexed citations
4.
Bas, Esperanza, M. Carmen Recio, Mohamed Abdallah, et al.. (2006). Inhibition of the pro-inflammatory mediators’ production and anti-inflammatory effect of the iridoid scrovalentinoside. Journal of Ethnopharmacology. 110(3). 419–427. 32 indexed citations
5.
Bas, Esperanza, M. Carmen Recio, Salvador Máñez, et al.. (2006). New insight into the inhibition of the inflammatory response to experimental delayed-type hypersensitivity reactions in mice by scropolioside A. European Journal of Pharmacology. 555(2-3). 199–210. 34 indexed citations
6.
Bas, Esperanza, M. Carmen Recio, Rosa M. Giner, et al.. (2006). Anti-Inflammatory Activity of 5-O-Demethylnobiletin, a Polymethoxyflavone Isolated fromSideritis tragoriganum. Planta Medica. 72(2). 136–142. 27 indexed citations
7.
Recio, M. Carmen, et al.. (2003). Isolation of Two Triterpenoids and a Biflavanone with Anti-Inflammatory Activity fromSchinus molleFruits. Planta Medica. 69(10). 893–898. 52 indexed citations
8.
Máñez, Salvador, M. Carmen Recio, Rosa M. Giner, et al.. (2001). Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. European Journal of Pharmacology. 428(1). 137–143. 169 indexed citations
9.
Máñez, Salvador, et al.. (2000). In Vivo Studies on the Anti-Inflammatory Activity of Pachymic and Dehydrotumulosic Acids. Planta Medica. 66(3). 221–227. 38 indexed citations
10.
Recio, M. Carmen, et al.. (1999). Anti-phospholipase A2 and anti-inflammatory activity of Santolina chamaecyparissus. Life Sciences. 66(2). PL35–PL40. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026